GoodRx (GDRX) Competitors $4.16 -0.08 (-1.77%) As of 01:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GDRX vs. ETSY, QBTS, STNE, HRI, FTDR, HNGE, WSC, RELY, DLO, and APLDShould you be buying GoodRx stock or one of its competitors? The main competitors of GoodRx include Etsy (ETSY), D-Wave Quantum (QBTS), StoneCo (STNE), Herc (HRI), Frontdoor (FTDR), Hinge Health (HNGE), WillScot (WSC), Remitly Global (RELY), DLocal (DLO), and Applied Digital (APLD). These companies are all part of the "business services" industry. GoodRx vs. Its Competitors Etsy D-Wave Quantum StoneCo Herc Frontdoor Hinge Health WillScot Remitly Global DLocal Applied Digital Etsy (NASDAQ:ETSY) and GoodRx (NASDAQ:GDRX) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Which has better valuation & earnings, ETSY or GDRX? Etsy has higher revenue and earnings than GoodRx. GoodRx is trading at a lower price-to-earnings ratio than Etsy, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEtsy$2.81B2.15$303.28M$1.2449.22GoodRx$792.32M1.83$16.39M$0.1041.75 Do institutionals & insiders believe in ETSY or GDRX? 99.5% of Etsy shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 2.8% of Etsy shares are held by insiders. Comparatively, 4.2% of GoodRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is ETSY or GDRX more profitable? Etsy has a net margin of 5.78% compared to GoodRx's net margin of 4.33%. GoodRx's return on equity of 8.86% beat Etsy's return on equity.Company Net Margins Return on Equity Return on Assets Etsy5.78% -31.10% 11.14% GoodRx 4.33%8.86%4.50% Do analysts prefer ETSY or GDRX? Etsy presently has a consensus target price of $57.80, indicating a potential downside of 5.30%. GoodRx has a consensus target price of $5.80, indicating a potential upside of 38.92%. Given GoodRx's stronger consensus rating and higher probable upside, analysts clearly believe GoodRx is more favorable than Etsy.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Etsy 3 Sell rating(s) 17 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.18GoodRx 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 Which has more volatility & risk, ETSY or GDRX? Etsy has a beta of 1.77, meaning that its share price is 77% more volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Does the media prefer ETSY or GDRX? In the previous week, Etsy had 21 more articles in the media than GoodRx. MarketBeat recorded 28 mentions for Etsy and 7 mentions for GoodRx. GoodRx's average media sentiment score of 0.86 beat Etsy's score of 0.51 indicating that GoodRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Etsy 12 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 4 Very Negative mention(s) Positive GoodRx 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryEtsy beats GoodRx on 11 of the 16 factors compared between the two stocks. Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GDRX vs. The Competition Export to ExcelMetricGoodRxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.45B$7.58B$5.75B$10.25BDividend YieldN/A2.86%5.88%4.63%P/E Ratio41.7575.9576.9526.52Price / Sales1.8336.81527.94122.10Price / Cash12.8224.1937.1760.46Price / Book2.217.2113.956.32Net Income$16.39M$241.92M$3.29B$270.92M7 Day Performance1.33%2.57%1.28%2.49%1 Month Performance11.93%3.17%5.00%6.95%1 Year Performance-44.99%2.57%84.58%27.73% GoodRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GDRXGoodRx3.8206 of 5 stars$4.16-1.8%$5.80+39.6%-44.9%$1.45B$792.32M41.65950Positive NewsShort Interest ↑ETSYEtsy3.6196 of 5 stars$58.20+7.7%$57.80-0.7%+10.3%$5.36B$2.81B24.682,400QBTSD-Wave Quantum1.5013 of 5 stars$15.40+0.2%$19.27+25.2%+1,828.0%$5.26B$8.83M0.003STNEStoneCo3.4777 of 5 stars$17.26-0.2%$15.36-11.0%+52.0%$4.95B$2.46B11.7716,793Positive NewsHRIHerc2.9054 of 5 stars$137.60-0.6%$144.60+5.1%-7.8%$4.60B$3.57B12.487,600FTDRFrontdoor3.5016 of 5 stars$65.27+3.5%$59.75-8.5%+35.1%$4.59B$1.84B16.082,120Positive NewsHNGEHinge HealthN/A$56.40+2.4%$55.73-1.2%N/A$4.32BN/A0.001,514WSCWillScot4.7124 of 5 stars$23.20-2.2%$36.00+55.2%-41.1%$4.32B$2.40B17.184,500Positive NewsRELYRemitly Global2.7832 of 5 stars$19.93+2.3%$29.00+45.5%+18.9%$4.02B$1.26B278.432,800Analyst ForecastDLODLocal3.0649 of 5 stars$13.36-0.4%$13.73+2.8%+72.2%$3.83B$745.97M22.751,095Analyst UpgradeAPLDApplied Digital1.9091 of 5 stars$13.91+0.1%$15.64+12.4%+230.4%$3.63B$144.19M0.00121Analyst Forecast Related Companies and Tools Related Companies Etsy Competitors D-Wave Quantum Competitors StoneCo Competitors Herc Competitors Frontdoor Competitors Hinge Health Competitors WillScot Competitors Remitly Global Competitors DLocal Competitors Applied Digital Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GDRX) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
